BTG3 and uveitis: When participants with ANA positivity at a titer of 1/160 or higher were grouped with different age cutoffs, an age < 5 years was associated with the highest risk of uveitis and bDMARD requirement (OR for uveitis 8.62 [2.50–29.81], OR for bDMARD utilization 4.92 [1.60–15.15]).